Strides Pharma gets approval for Solifenacin SuccinateTablets
Strides Pharma gets approval for Solifenacin SuccinateTablets

Strides Pharma gets approval for Solifenacin SuccinateTablets

DSIJ Intelligence Article rating: 3.5

The company informed on Friday that Stride Pharma Global Pte Limited, Singapore, has received approval from the United States Food and Drug Administration (USFDA) for manufacturing Solifenacin SuccinateTablets, 5 mg and 10 mg.

iGTB of Intellect Design organises Sibos networking cruise
iGTB of Intellect Design organises Sibos networking cruise

iGTB of Intellect Design organises Sibos networking cruise

DSIJ Intelligence Article rating: 5.0

Intellect Global Transaction Banking (iGTB), the transaction banking and tech specialist from Intellect Design Arena Limited, in partnership with Fintech Power 50 on Tuesday organised a SIBOS networking cruise that brings together major banks, insurers and market infrastructure players.

NTPC set to operate Lara Super Thermal Power Station
NTPC set to operate Lara Super Thermal Power Station

NTPC set to operate Lara Super Thermal Power Station

Pratik Shastri Article rating: 4.8

The company said NTPC is all set to start commercial operation of Unit-1 of 800 MW of Lara Super Thermal Power Station (2 x 800 MW) with effective from September 30, 2019. 

Ten stocks close to their 52-weeks high
Ten stocks close to their 52-weeks high

Ten stocks close to their 52-weeks high

DSIJ Intelligence Article rating: 4.5

The markets on September 27, 2019 opened gap down. BSE Sensex is trading at 38,933.01, down by 56.73 points and the Nifty is trading at 11,546.70, down by 24.50 points. 

RSS
First31053106310731083110311231133114Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR